Health Catalyst, Inc.·4

May 4, 5:17 PM ET

Nelson Steven H 4

4 · Health Catalyst, Inc. · Filed May 4, 2026

Research Summary

AI-generated summary of this filing

Updated

Health Catalyst (HCAT) Director Steven H. Nelson Receives RSU Award

What Happened
Steven H. Nelson, a Health Catalyst (HCAT) director, received an award of 154,808 restricted stock units (RSUs) on 2026-05-01. The Form 4 reports an acquisition price of $0.00 for the award (transaction code A). Each RSU represents a contingent right to one share of common stock and will convert to shares as the RSUs vest.

Key Details

  • Transaction date: 2026-05-01; filing date: 2026-05-04 (Accession No. 0001320490-26-000002). No late-filing flag is shown in the report.
  • Award size: 154,808 RSUs; reported acquisition price: $0.00 (grant value not specified on Form 4).
  • Vesting: 33.33% vests on May 1, 2027; the remaining 66.67% vests in two equal annual installments thereafter (per footnote).
  • Shares owned after transaction: not specified in the provided filing.
  • Footnote: The award was granted under the 2019 Stock Option and Incentive Plan and Issuer’s Non-Employee Director Compensation Policy (see F1 for vesting schedule).

Context
This is an equity compensation award (not a market purchase or sale). RSU grants to non-employee directors are common as part of routine director compensation and do not by themselves indicate a buy/sell signal. The RSUs are contingent until they vest and convert to actual shares; any tax withholding or share withholding at vesting would be reported separately if it occurred.

Insider Transaction Report

Form 4
Period: 2026-05-01
Transactions
  • Award

    Common Stock

    [F1]
    2026-05-01+154,808154,808 total
Footnotes (1)
  • [F1]Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 33.33% of the RSUs will vest on May 1, 2027 and, thereafter, the remaining 66.67% of the RSUs will vest in 2 equal annual installments.
Signature
/s/ Benjamin Landry, as Attorney-in-Fact|2026-05-04

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT